| Literature DB >> 26504284 |
Syamala Buragadda1, Adel A Alhusaini1, Ganeswara Rao Melam1, Nisha Arora2.
Abstract
[Purpose] Post mastectomy lymphedema is common among breast cancer survivors. It leads to physical discomfort and functional impairment. Rehabilitation forms the mainstay of treatment and is multidisciplinary.Entities:
Keywords: Breast cancer; Manual lymphatic drainage; Post mastectomy lymphedema
Year: 2015 PMID: 26504284 PMCID: PMC4616085 DOI: 10.1589/jpts.27.2743
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Flow chart for the sample recruitment
Descriptive statistics of the sample
| Variables | Group A | Group B | |
|---|---|---|---|
| Age (years) | 56.3±3.3 | 56±3.5 | |
| Educational level | Literate | 25 (42%) | 27 (45%) |
| Illiterate | 5 (8%) | 3 (5%) | |
| Marital status | Single | 4 (7%) | 5 (8%) |
| Married | 26 (43%) | 25 (42%) | |
| Type of surgery | Radical Mastectomy | 17 (43%) | 18 (45%) |
| Modified Radical Mastectomy | 3 (8%) | 2 (5%) | |
| Affected Arm | Dominant | 15 (38%) | 14 (35%) |
| Non Dominant | 5 (13%) | 6 (15%) | |
Arm circumference measurements of the groups
| Outcome | Baseline (cm) (M±SD) | 95% CI | 4th week (cm) | 95% CI | 6th week (cm) | 95% CI | |
|---|---|---|---|---|---|---|---|
| Conventional treatment group (n=30) | |||||||
| Wrist | 17.9±1.1 | 16–22 | 16.7±1.1 | 14–19 | 15.7±1.1 | 13–17 | |
| Mid forearm | 20.9±1.2 | 18–24.5 | 19.7±1.3 | 16–23 | 18.8±1.4 | 15–22 | |
| Elbow | 23.3±1.5 | 20–28 | 22.5±2.6 | 19–27 | 21.1±1.6 | 17–26 | |
| Mid-arm | 25.1±1.5 | 21–31 | 23.7±1.8 | 19–31 | 22.8±1.8 | 17–30 | |
| Axilla | 27.0±1.8 | 23–32 | 25.7±1.9 | 21–30 | 24.6±1.9 | 20–30 | |
| CDT group (n=30) | |||||||
| Wrist | 18.7±1.2 | 15.5–20.3 | 16.6±1.3 | 14.2–19.4 | 15.1±1.1 | 13.3–18.6 | |
| Mid forearm | 20.9±1.4 | 18.5–23.2 | 18.9±1.5 | 16.3–22.4 | 17.2±1.5 | 15.2–21.5 | |
| Elbow | 23.1±1.7 | 19.3–26.6 | 21.2±1.83 | 17.8–34.1 | 19.5±1.9 | 16.5–24.8 | |
| Mid-arm | 24.8±1.96 | 21.4–28.7 | 22.87±2.3 | 18.2–27.2 | 21.2±2.3 | 17.4–26.5 | |
| Axilla | 26.5±2.3 | 23.3–33 | 24.7±2.3 | 21.2–32.2 | 23±2.6 | 19.3–30.1 | |
Values are mean± SD; CI: confidence interval; cm: centimeters
Volume, DASH and pain scores of the groups
| Outcome | Baseline (M±SD) | 95% CI | 4th week | 95% CI | 6th week | 95% CI | |
|---|---|---|---|---|---|---|---|
| Conventional treatment group (n=30) | |||||||
| Pain | 6.9±1.1 | 4.2–8.2 | 4.5± 0.9 | 2.1–4.8 | 2.9± 0.6 | 1–1.9 | |
| DASH score | 32.6±1.5 | 30–36 | 7.9±0.8 | 5.8–9.3 | 5.±1.1 | 1.6–3.3 | |
| Lymphedema | 1,974±171.3 | 1,596–2,553 | 1,757.6±186.71 | 1,302–2,201 | 1,599.7±191.4 | 1,031–2,102 | |
| Complete decongestive therapy group (n=30) | |||||||
| Pain | 6.8 ± 0.9 | 4.2–8.5 | 3.2 ± 0.7 | 3.1–6.3 | 1.4 ± 0.2 | 2–4.7 | |
| DASH score | 32.6 ± 1.4 | 30–35 | 6.7 ± 0.7 | 6.6–10 | 2 ± 0.5 | 3.3–7.5 | |
| Lymphedema (cm3) | 1,996.4± 279.3 | 1,311–2,502 | 1,657.2±254.1 | 1,278–2,105 | 1,412.5±219.2 | 1,065–1,904 | |
Values are mean± SD; CI: confidence interval; cm: centimeters